IT Cost Optimisation: Part 2 – The Art and Science of Right-Sizing



11 August, 2025 | Brandon Salem

Why Regular Information Security Reviews Are Critical in Biotech and Pharma



4 August, 2025 | Valeriy Naydonov

Using Microsoft Teams? Don’t Assume It’s Safe – Verify



24 July, 2025 | Valeriy Naydonov

Uncovering the Unknown



24 July, 2025 | Valeriy Naydonov

Ingram Micro Outage: A Critical Reminder of Third-Party Risk



7 July, 2025 | Brandon Salem

Unmasking the Invisible: Why True Security Starts with Visibility



20 June, 2025 | Brandon Salem

IT Cost Optimisation: Part 1 – Redundant Software



4 June, 2025 | Brandon Salem

Security Is Not a Checklist – A Deeper Dive



15 May, 2025 | Brandon Salem

CIPP Vulnerability Finding – A Third-Party Risk Story



17 March, 2025 | Brandon Salem

Protecting Biotech and Pharma Companies in the Age of AI: Imperatives and Risks



30 December, 2024 | Dr Irving Hofman